Fluid management of Acute decompensated heart failure Subjects Treated with Reprieve Decongestion Management System (DMS) (FASTR)
Principal Investigator: Dr. Jonathon Moreno
Study Coordinators: Stephanie Stilinovic and Amen Zelleke
The purpose of this study is to test a treatment approach for subjects with acute decompensated heart failure who come to the hospital or the emergency room and require treatment for their fluid volume overload and need to remove excess fluids. The Reprieve DMS is designed to provide an efficient method of safe and rapid fluid loss and to produce the desired urine output to relieve patients of their heart failure symptoms.
To learn more about FASTR and how you can join contact our research office at (314) 289-7690
This study is a joint study with the St. Louis VA and Washington University in St. Louis
The study is funded by our Foundation through Reprieve Cardiovascular, Inc
Study Coordinators: Stephanie Stilinovic and Amen Zelleke
The purpose of this study is to test a treatment approach for subjects with acute decompensated heart failure who come to the hospital or the emergency room and require treatment for their fluid volume overload and need to remove excess fluids. The Reprieve DMS is designed to provide an efficient method of safe and rapid fluid loss and to produce the desired urine output to relieve patients of their heart failure symptoms.
To learn more about FASTR and how you can join contact our research office at (314) 289-7690
This study is a joint study with the St. Louis VA and Washington University in St. Louis
The study is funded by our Foundation through Reprieve Cardiovascular, Inc